
Sign up to save your podcasts
Or


In this episode, we discuss the recently published DOSE VF trial, which evaluated the efficacy of early double sequential defibrillation strategy over vector change and standard defibrillation strategies.
This trial has demonstrated that this innovative strategy has the potential to improve mortality and is likely to change our practices.
By Swapnil Pawar4.5
44 ratings
In this episode, we discuss the recently published DOSE VF trial, which evaluated the efficacy of early double sequential defibrillation strategy over vector change and standard defibrillation strategies.
This trial has demonstrated that this innovative strategy has the potential to improve mortality and is likely to change our practices.